Watching You …

Premium

A team of researchers in Germany has developed a device that can be implanted near a tumor to monitor its growth, reports Technology Review's Kate Baggott. The implant — called the Intelligent Implant for Tumor Monitoring, or IntelliTum — uses sensors to measure oxygen and pH levels in the blood, which can indicate whether a tumor is growing or not. The data is sent to an external receiver that the patient carries and can then be sent to the doctor for analysis, Baggott says.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more